Approvals of BioSimilars in Europe
Are BioSimilars Being Approved in the US?
Biologics Price Competition and Innovation Act
Biologics vs Small Molecules
BioSimilar Patenting Litigation Involving Large Amounts of Money
Claim Maps and BioSimilars
Demonstrating BioSimilarity Under U.S. Law
FDA Guidelines for Demonstrating Biosimilarity
How to Navigate BioSimilar Challenges
Impact of US Hatch Waxman Act 1984
Litigation and BioSimilar Patenting
Naming Problems with BioSimilars
What is a BioSimilar?
What is a BioSimilar Product Under US Law?
Who Determines Substitution Factors?
Why Are Biologicals so Important?
Return to Intellectual Property